Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?
about
Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-βBeyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the ClinicCancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Stem cell competition: finding balance in the nicheDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentGenetics of gonadal stem cell renewalMyeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia.Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma.Induction of malignant plasma cell proliferation by eosinophilsHuman CD34(lo)CD133(lo) fetal liver cells support the expansion of human CD34(hi)CD133(hi) hematopoietic stem cells.Cytotherapies in multiple myeloma: a complementary approach to current treatments?Bone marrow neoplastic niche in leukemia.Myeloma bone disease: pathogenesis, current treatments and future targets.Osteoblastic niche supports the growth of quiescent multiple myeloma cells.Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model.
P2860
Q26745943-948B91EC-4A54-4C73-BDEB-BD39E88727F0Q26752778-9CD12A13-0B0C-4101-97CC-6114AC1586BBQ26785497-E88FE246-A450-4241-BB48-44E96082B984Q27009202-A6415231-94E8-4C8D-BF30-FB9DB4438352Q27025321-8A2F3E33-909D-4984-8A56-EB9022A9973BQ28082639-833CA537-BC5B-4DE3-8481-CD00A3EF9D5AQ33558170-5C853296-3A6A-492F-BBA4-D5B33E1F2D85Q33731691-A03CE0F1-C148-47AB-BB62-91C659764489Q34556156-01DB2D99-1E64-449B-A920-99170A971011Q34876626-D7B9A53D-DF7E-4D2D-9518-C38BD86923E7Q37284991-CDB3B0AD-62B0-4CD8-A68B-6234EF624D1CQ38108819-D2C7D65F-5BE5-4EE9-A8D3-FDCD431CED61Q38125795-318DBB1A-3108-44BB-8A33-CC49C58D368FQ38246241-9F3464B3-C60E-448C-8DDD-FEFBCC322D42Q38611227-C1438196-F5A0-4D09-BFAC-AA0EFABF6BFFQ38824383-C3435946-C1A7-44C6-8E44-269F4E1374DAQ38960721-E6E4DA1B-6E0D-4D80-B3FB-B463D6FEB031Q55261755-776CC620-3CB9-437C-BECD-A154D853EE9F
P2860
Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tug of war in the haematopoiet ...... lls compete for the HSC niche?
@ast
Tug of war in the haematopoiet ...... lls compete for the HSC niche?
@en
type
label
Tug of war in the haematopoiet ...... lls compete for the HSC niche?
@ast
Tug of war in the haematopoiet ...... lls compete for the HSC niche?
@en
prefLabel
Tug of war in the haematopoiet ...... lls compete for the HSC niche?
@ast
Tug of war in the haematopoiet ...... lls compete for the HSC niche?
@en
P2860
P50
P356
P1433
P1476
Tug of war in the haematopoiet ...... lls compete for the HSC niche?
@en
P2093
S A Williams
P2860
P2888
P356
10.1038/BCJ.2012.38
P577
2012-09-14T00:00:00Z